Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Journal of Alzheimer'S Disease : JAD
|
June 30, 2020
Ethical and Social Implications of Using Predictive Modeling for Alzheimer's Disease Prevention: A Systematic Literature Review
Zuzanna Angehrn, Jelena Sostar, Clementine Nordon, et al.
Acta Ophthalmologica
|
September 19, 2022
Efficacy and safety of brolucizumab in age-related macular degeneration: A systematic review of real-world studies
Caroline R Baumal, Torben Lykke Sørensen, Helene Karcher, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 23, 2016
The "Efficacy-Effectiveness Gap": Historical Background and Current Conceptualization
Clementine Nordon, Helene Karcher, Rolf H H Groenwold, et al.
Pharmaceutics
|
January 25, 2025
Visual Acuity Outcomes and Influencing Factors in a Cohort of UK Real-World Diabetic Macular Oedema Patients During the First Two Years of Anti-VEGF Treatment
Qing Wen, Helene Karcher, David M Wright, et al.
Schizophrenia Research
|
July 18, 2017
Trial exclusion criteria and their impact on the estimation of antipsychotic drugs effect: A case study using the SOHO database
Clementine Nordon, Thomas Bovagnet, Mark Belger, et al.
JAMA Network Open
|
September 13, 2021
Proportion of Women and Reporting of Outcomes by Sex in Clinical Trials for Alzheimer Disease: A Systematic Review and Meta-analysis
Julie Martinkova, Frances-Catherine Quevenco, Helene Karcher, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)
|
March 4, 2025
Disease Onset and Burden in Patients With Chronic Bronchitis and COPD: A Real-World Evidence Study
Jamuna K Krishnan, Gerard J Criner, Bilal H Lashari, et al.
Ophthalmology and Therapy
|
May 28, 2025
Real-World Outcomes of Brolucizumab Treatment in Japanese Patients with Neovascular Age-Related Macular Degeneration: A 12-Month, Multicenter Study
Masayuki Ohnaka, Yoichi Sakurada, Atsushi Hayashi, et al.
Ophthalmology and Therapy
|
March 23, 2024
Real-World Safety Outcomes with Brolucizumab in Neovascular Age-Related Macular Degeneration: Findings from the IRIS® Registry
Marco A Zarbin, Mathew W MacCumber, Helene Karcher, et al.
Ophthalmology
|
April 22, 2023
One-Year Brolucizumab Outcomes in Neovascular Age-Related Macular Degeneration from a Large United States Cohort in the IRIS® Registry
Mathew W MacCumber, Charles C Wykoff, Helene Karcher, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Journal of Alzheimer'S Disease : JAD
|
June 30, 2020
Ethical and Social Implications of Using Predictive Modeling for Alzheimer's Disease Prevention: A Systematic Literature Review
Zuzanna Angehrn, Jelena Sostar, Clementine Nordon, et al.
Acta Ophthalmologica
|
September 19, 2022
Efficacy and safety of brolucizumab in age-related macular degeneration: A systematic review of real-world studies
Caroline R Baumal, Torben Lykke Sørensen, Helene Karcher, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 23, 2016
The "Efficacy-Effectiveness Gap": Historical Background and Current Conceptualization
Clementine Nordon, Helene Karcher, Rolf H H Groenwold, et al.
Pharmaceutics
|
January 25, 2025
Visual Acuity Outcomes and Influencing Factors in a Cohort of UK Real-World Diabetic Macular Oedema Patients During the First Two Years of Anti-VEGF Treatment
Qing Wen, Helene Karcher, David M Wright, et al.
Schizophrenia Research
|
July 18, 2017
Trial exclusion criteria and their impact on the estimation of antipsychotic drugs effect: A case study using the SOHO database
Clementine Nordon, Thomas Bovagnet, Mark Belger, et al.
JAMA Network Open
|
September 13, 2021
Proportion of Women and Reporting of Outcomes by Sex in Clinical Trials for Alzheimer Disease: A Systematic Review and Meta-analysis
Julie Martinkova, Frances-Catherine Quevenco, Helene Karcher, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)
|
March 4, 2025
Disease Onset and Burden in Patients With Chronic Bronchitis and COPD: A Real-World Evidence Study
Jamuna K Krishnan, Gerard J Criner, Bilal H Lashari, et al.
Ophthalmology and Therapy
|
May 28, 2025
Real-World Outcomes of Brolucizumab Treatment in Japanese Patients with Neovascular Age-Related Macular Degeneration: A 12-Month, Multicenter Study
Masayuki Ohnaka, Yoichi Sakurada, Atsushi Hayashi, et al.
Ophthalmology and Therapy
|
March 23, 2024
Real-World Safety Outcomes with Brolucizumab in Neovascular Age-Related Macular Degeneration: Findings from the IRIS® Registry
Marco A Zarbin, Mathew W MacCumber, Helene Karcher, et al.
Ophthalmology
|
April 22, 2023
One-Year Brolucizumab Outcomes in Neovascular Age-Related Macular Degeneration from a Large United States Cohort in the IRIS® Registry
Mathew W MacCumber, Charles C Wykoff, Helene Karcher, et al.
Page
of 4